ZNF106 and amyotrophic lateral sclerosis: However, co-expression of Zfp106 with GGGGCC repeat-containing RNAs ameliorates these phenotypes, suggesting that Zfp106 protects neurons from hexanucleotide repeat toxicity and may represent a potential therapeutic target for ALS [23].